Lighthouse Investment Partners’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,050
Closed -$6.5M 904
2025
Q4
$6.5M Buy
6,050
+550
+10% +$526K 0.2% 147
2025
Q3
$4.2M Buy
5,500
+300
+6% +$223K 0.13% 217
2025
Q2
$4.05M Buy
5,200
+3,200
+160% +$2.49M 0.15% 201
2025
Q1
$1.65M Buy
+2,000
New +$1.66M 0.07% 283
2024
Q3
Sell
-25,538
Closed -$23.1M 501
2024
Q2
$23.1M Buy
25,538
+19,804
+345% +$15.8M 0.92% 13
2024
Q1
$4.46M Sell
5,734
-4,848
-46% -$3.45M 0.21% 142
2023
Q4
$6.17M Buy
10,582
+2,014
+24% +$1.18M 0.28% 81
2023
Q3
$4.6M Buy
+8,568
New +$4.42M 0.19% 127

Other funds holding LLY

Lighthouse Investment Partners's LLY Position: Q1 2026 in Review

Lighthouse Investment Partners sold out of Eli Lilly (LLY) in Q1 2026, closing a stake of 6,050 shares — an estimated $6.5M sold.

Lighthouse Investment Partners first reported a position in LLY in Q3 2023 and held it in 8 quarters. The position peaked at $23.1M in Q2 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Lighthouse Investment Partners reported no remaining Eli Lilly position as of Q1 2026 after selling out during the quarter.
  • Lighthouse Investment Partners sold 6,050 Eli Lilly shares in Q1 2026, an estimated $6.5M.
  • Lighthouse Investment Partners first reported a position in Eli Lilly in Q3 2023 and held it in 8 quarters.
  • Lighthouse Investment Partners's Eli Lilly position peaked at $23.1M in Q2 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Lighthouse Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.